Validation of a New Device to Measure Neuromuscular Disease Progression

Completed

Conditions studied: Amyotrophic Lateral Sclerosis & Other Neuromuscular Disorders

In brief

There is a great need for the development of sensitive outcomes that allow experimental drugs to be tested in human subjects more efficiently. If we could more precisely measure whether an experimental drug slows the progression of ALS or other neuromuscular diseases, this would allow more drugs to be tested quicker and at less expense. We have developed a new device that accurately measures isometric strength called: Accurate Test of Limb Isometric Strength (ATLIS). This device was designed to be portable, quick, and easy to use, while generating accurate and reliable, interval level data. This study will enable us to test the reliability and validity of ATLIS.

Key facts

Study ID
NCT00606918
Run by
Massachusetts General Hospital
People needed
120
Starts
2008-01-01
Expected to finish
2010-09-01
Last updated by the study team
2011-05-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.